Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

High Sheriff of Oxfordshire Imam Monawar Hussain presents the Outstanding Technical Leadership: Therapeutic Innovation award to Adrian Hill

Part of the High Sheriff of Oxfordshire’s Covid Heroes programme, the awards presented the Institute with the Outstanding Technical Leadership: Therapeutic Innovation honour. This was in recognition of its incredible work to develop, pilot, organise clinical trials for, scale-up and roll-out – in partnership with AstraZeneca – the COVID-19 vaccine in such a short space of time, saving millions of lives across the world.

Professor Adrian Hill KBE, Director of the Jenner Institute & Lakshmi Mittal & Family Professor of Vaccinology who received the award on the Institute’s behalf, said: ‘The COVID-19 vaccine response provides an excellent illustration of the strong links between academia and industry in the UK, with a vaccine candidate from the Jenner Institute at Oxford moving rapidly to many UK industrial partners in early 2021 and then onto many more manufacturing sites internationally – providing over 2 billion doses for 180 countries.’

Read the full story on the University of Oxford website

Similar stories

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.

Showcasing Oxford’s translational research for Rare Disease Day

Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.